Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3073% above fair value
$320.01−0.59 (-0.18%)
Close on Nov 19, 2026Market cap $12.61BP/E 80.6Yield –
Penumbra revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Penumbra's revenue for the twelve months ending Sep 30, 2026 was $1.56B, up 17.0% year over year. For fiscal 2025 it was $1.40B, up 17.5% from the year before. Over ten years it grew 22.4% a year on average. The highest annual figure on record is $1.40B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40B | +17.5% |
| FY2024 | Dec 31, 2024 | $1.19B | +12.9% |
| FY2023 | Dec 31, 2023 | $1.06B | +25.0% |
| FY2022 | Dec 31, 2022 | $847.13M | +13.3% |
| FY2021 | Dec 31, 2021 | $747.59M | +33.4% |
| FY2020 | Dec 31, 2020 | $560.41M | +2.4% |
| FY2019 | Dec 31, 2019 | $547.41M | +23.0% |
| FY2018 | Dec 31, 2018 | $444.94M | +33.3% |
| FY2017 | Dec 31, 2017 | $333.76M | +26.8% |
| FY2016 | Dec 31, 2016 | $263.32M | +41.5% |
| FY2015 | Dec 31, 2015 | $186.10M | +48.3% |
| FY2014 | Dec 31, 2014 | $125.51M | +41.3% |
| FY2013 | Dec 31, 2013 | $88.85M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $410.15M | +15.6% |
| Q2 FY2026 | Jun 30, 2026 | $390.05M | +14.9% |
| Q1 FY2026 | Mar 31, 2026 | $374.76M | +15.6% |
| Q4 FY2025 | Dec 31, 2025 | $385.39M | +22.1% |
| Q3 FY2025 | Sep 30, 2025 | $354.69M | +17.8% |
| Q2 FY2025 | Jun 30, 2025 | $339.46M | +13.4% |
| Q1 FY2025 | Mar 31, 2025 | $324.14M | +16.3% |
| Q4 FY2024 | Dec 31, 2024 | $315.52M | +10.8% |
| Q3 FY2024 | Sep 30, 2024 | $301.04M | +11.1% |
| Q2 FY2024 | Jun 30, 2024 | $299.40M | +14.5% |
| Q1 FY2024 | Mar 31, 2024 | $278.66M | +15.4% |
| Q4 FY2023 | Dec 31, 2023 | $284.68M | +28.7% |
| Q3 FY2023 | Sep 30, 2023 | $270.95M | +26.8% |
| Q2 FY2023 | Jun 30, 2023 | $261.50M | +25.5% |
| Q1 FY2023 | Mar 31, 2023 | $241.40M | +18.4% |
| Q4 FY2022 | Dec 31, 2022 | $221.22M | +8.4% |
| Q3 FY2022 | Sep 30, 2022 | $213.68M | +12.4% |
| Q2 FY2022 | Jun 30, 2022 | $208.34M | +13.1% |
| Q1 FY2022 | Mar 31, 2022 | $203.90M | +20.5% |
| Q4 FY2021 | Dec 31, 2021 | $204.01M | +22.2% |
| Q3 FY2021 | Sep 30, 2021 | $190.12M | +25.8% |
| Q2 FY2021 | Jun 30, 2021 | $184.26M | +75.3% |
| Q1 FY2021 | Mar 31, 2021 | $169.20M | +23.2% |
| Q4 FY2020 | Dec 31, 2020 | $166.90M | +14.9% |
| Q3 FY2020 | Sep 30, 2020 | $151.08M | +8.3% |
| Q2 FY2020 | Jun 30, 2020 | $105.11M | -21.7% |
| Q1 FY2020 | Mar 31, 2020 | $137.33M | +6.9% |
| Q4 FY2019 | Dec 31, 2019 | $145.26M | +20.3% |
| Q3 FY2019 | Sep 30, 2019 | $139.50M | +24.8% |
| Q2 FY2019 | Jun 30, 2019 | $134.20M | +22.4% |
| Q1 FY2019 | Mar 31, 2019 | $128.44M | +25.1% |
| Q4 FY2018 | Dec 31, 2018 | $120.79M | +25.8% |
| Q3 FY2018 | Sep 30, 2018 | $111.81M | +33.2% |
| Q2 FY2018 | Jun 30, 2018 | $109.64M | +36.0% |
| Q1 FY2018 | Mar 31, 2018 | $102.70M | +40.3% |
| Q4 FY2017 | Dec 31, 2017 | $96.05M | +31.4% |
| Q3 FY2017 | Sep 30, 2017 | $83.91M | – |
| Q2 FY2017 | Jun 30, 2017 | $80.59M | – |
| Q1 FY2017 | Mar 31, 2017 | $73.21M | – |
| Q4 FY2016 | Dec 31, 2016 | $73.11M | – |
See a number that looks wrong?